How Much GLP-1 Weight Loss Is Fat vs Muscle?

When you lose weight on a GLP-1, not all of that weight is fat. Some of it is lean mass: muscle, organ tissue, and the water they hold. This is true of essentially every form of weight loss, not just medication, but it gets asked about more with GLP-1s because the total losses can be large and fast. The useful question is not “am I losing any muscle?” (you almost certainly are) but “what share of my loss is fat versus lean, and can I shift that in my favor?”

If you want to estimate how much total weight you might lose first, our GLP-1 weight loss projector gives you a starting figure to work from.

Doctor, stethoscope, man — illustrating How Much GLP-1 Weight Loss Is Fat vs Muscle?

The baseline: about a quarter of any weight loss is lean

Start with the general rule, because GLP-1s mostly follow it. Across decades of weight-loss research, roughly 25% of the weight lost during calorie restriction comes from fat-free mass (lean tissue) and about 75% from fat. This “quarter rule” is a well-established average for diet-driven weight loss without specific muscle-protecting measures. It is the yardstick to hold the drug data against.

The important nuance: some lean-mass loss during weight loss is expected and not inherently alarming. When you shrink, your body needs less structural tissue to carry and move a smaller frame, and it sheds some accordingly. The concern is when the lean share runs high: when too much of what you lose is muscle rather than fat.

GLP-1 weight loss is a mix of fat and lean mass: the DEXA substudies put lean tissue at roughly a quarter of the total, similar to diet-based weight loss.

What the semaglutide data shows (STEP 1)

The STEP 1 trial included a DEXA substudy that measured body composition directly. The results were more encouraging than the “muscle-wasting” headlines suggest. Over 68 weeks, semaglutide produced a 19.3% reduction in total fat mass and a 9.7% reduction in total lean body mass. Because fat fell proportionally faster than lean, the ratio of lean mass to fat mass improved by 0.23 over the trial, and lean mass as a proportion of total body mass rose by about 3 percentage points. Regional visceral fat (the metabolically harmful kind around the organs) dropped by 27.4%.

In plain terms: participants lost both compartments, but they ended up leaner as a proportion of their new body, not less lean. The improvement in the lean-to-fat ratio was strongest in people who lost the most weight (a 0.41 improvement in those losing ≥15%, versus almost no change in those losing <15%). That is the opposite of the fear that big losses mean gutted muscle.

Face masks, sanitizer, coronavirus — illustrating How Much GLP-1 Weight Loss Is Fat vs Muscle?

What the tirzepatide data shows (SURMOUNT-1)

Tirzepatide’s SURMOUNT-1 trial ran a DXA substudy too, and it reported the split cleanly. The table below compares the two compartments:

Compartment	Tirzepatide	Placebo
Fat mass change	−33.9% (−15.9 kg)	−8.2% (−3.6 kg)
Lean mass change	−10.9% (−5.6 kg)	−2.6% (−1.2 kg)
Share of weight lost as fat	~74%	~75%
Share of weight lost as lean	~26%	~25%

The headline number: about 74% of the weight lost on tirzepatide was fat and about 26% was lean, essentially the same fat-to-lean split seen with placebo-level, diet-driven loss, and right in line with the classic quarter rule. The trial authors noted this ~75/25 proportion held steady across age, sex, and the amount of weight lost. So tirzepatide did not spare muscle beyond what ordinary weight loss does, but it did not make the ratio worse either; it drove far more total loss at a normal composition.

Putting the two together

Across both drugs, the picture is consistent and fairly reassuring. GLP-1 weight loss splits roughly three-to-one in favor of fat, matching what happens with diet alone. Semaglutide’s data even showed the lean-to-fat ratio improving. The lean mass you lose is real, but it is a minority of the total and mostly the expected consequence of getting smaller, not evidence the drug is uniquely bad for muscle.

Two honest caveats keep this from being the whole story. First, these are substudies and exploratory analyses with modest sample sizes, and DEXA cannot perfectly separate muscle from other lean tissue and water, so treat the exact percentages as good estimates, not precise truths. Second, “normal proportion” still means absolute pounds of lean tissue are gone, and for older adults or people already low on muscle, protecting what remains matters more. We go deeper on that risk in our companion piece on GLP-1s and muscle loss.

Doctor, patient, consultation — illustrating How Much GLP-1 Weight Loss Is Fat vs Muscle?

How to shift the ratio in your favor

The good news is that the fat-to-lean split is not fixed: it responds to what you do while losing weight. Two levers have the strongest evidence:

Resistance training. This is the single most effective way to preserve lean mass in a deficit. In controlled comparisons, resistance-trained groups mostly held or even gained fat-free mass while losing fat, whereas aerobic-only and no-exercise groups lost lean tissue: one analysis found 85% of resistance-training participants gained lean body mass versus 39% doing aerobic exercise alone. Lifting tells the body the muscle is still needed.
Adequate protein. Protein intake supports muscle retention during weight loss, and it matters more when appetite is suppressed and total food volume drops, which is exactly the GLP-1 situation. Getting enough becomes a deliberate effort rather than an accident. Our guide on why protein matters more on a GLP-1 covers the targets and how to hit them.

Neither of these eliminates lean-mass loss, and neither is a substitute for medical guidance. But together they reliably push the split further toward fat, turning “normal” body-composition loss into higher-quality loss.

The takeaway

On a GLP-1, roughly a quarter of the weight you lose is lean mass and roughly three-quarters is fat, the same broad split as diet-driven weight loss. SURMOUNT-1 put tirzepatide’s loss at about 74% fat and 26% lean; STEP 1 showed semaglutide cutting fat faster than lean and improving the lean-to-fat ratio. Some lean loss is normal and expected, but you can tilt the ratio toward fat by lifting weights and eating enough protein.

To see how much total weight you might be working with in the first place, try our GLP-1 weight loss projector. This article is educational and not medical advice; talk to your clinician before making changes to your medication, diet, or training.